Tick saliva is a rich source of modulators of vascular biology. We have characterized Ixonnexin, a member of the "Basic-tail" family of
salivary proteins from the tick Ixodes scapularis. Ixonnexin is a 104 residues (11.8 KDa), non-enzymatic basic
protein which contains 3
disulfide bonds and a C-terminal rich in
lysine. It is homologous to SALP14, a tick salivary FXa
anticoagulant. Ixonnexin was produced by
ligation of synthesized fragments (51-104) and (1-50) followed by folding. Ixonnexin, like SALP14, interacts with FXa. Notably, Ixonnexin also modulates fibrinolysis in vitro by a unique salivary mechanism. Accordingly, it accelerates
plasminogen activation by
tissue-type plasminogen activator (t-PA) with Km 100 nM; however, it does not affect
urokinase-mediated fibrinolysis. Additionally,
lysine analogue ε-
aminocaproic acid inhibits Ixonnexin-mediated
plasmin generation implying that
lysine-binding sites of Kringle domain(s) of
plasminogen or t-PA are involved in this process. Moreover, surface plasmon resonance experiments shows that Ixonnexin binds t-PA, and
plasminogen (KD 10 nM), but not
urokinase. These results imply that Ixonnexin promotes fibrinolysis by supporting the interaction of
plasminogen with t-PA through formation of an enzymatically productive ternary complex. Finally, in vivo experiments demonstrates that Ixonnexin inhibits FeCl3-induced
thrombosis in mice. Ixonnexin emerges as novel modulator of fibrinolysis which may also affect parasite-vector-host interactions.